| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/06/2000 | US6072035 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 06/06/2000 | US6071974 Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation |
| 06/06/2000 | US6071964 Decreased gastrointestinal irritation, increased bioavailability |
| 06/06/2000 | US6071963 Water dispersible compositions |
| 06/06/2000 | US6071961 For treating gastritis caused by caphylobacteria by administeing microbiocide comprising aliphatic or aromatic fatty acid, hydrotope and compatible acid |
| 06/06/2000 | US6071959 For relieving pain of lower gastrointestinal tract by rectal or oral administration of a complex of amide-type local anaesthetic and polyacrylate with carrier, diluent and/or excipient |
| 06/06/2000 | US6071956 Treatment of tissues to reduce subsequent response to injury |
| 06/06/2000 | US6071952 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 06/06/2000 | US6071942 Elevation of circulating blood histamine levels |
| 06/06/2000 | US6071924 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 06/06/2000 | US6071896 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 06/06/2000 | US6071890 Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| 06/06/2000 | US6071538 Oral delivery composition comprising supramolecular complex |
| 06/06/2000 | US6071533 Mixing with hydrophilic polymer to increase shelf life |
| 06/06/2000 | US6071531 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 06/06/2000 | US6071530 Dispensing solution of biodegradable, water insoluble, thermoplastic resin with biocompatible solvent onto support; coagulation |
| 06/06/2000 | US6071524 Unsaturated fatty acid monoglyceride, phytanetriol, and surfactant; cosmetics |
| 06/06/2000 | US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery |
| 06/06/2000 | US6071519 Treating autoimmune diseases, hodgkin's disease and other lymph cancers |
| 06/06/2000 | US6071510 Modified amino acids and compositions comprising the same for delivering active agents |
| 06/06/2000 | US6071495 Targeted gas and gaseous precursor-filled liposomes |
| 06/06/2000 | US6071491 Administering an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled |
| 06/06/2000 | US6071447 Cross-linking a biological polymer with a cross-linking agent and loading the cross-linked biopolymer with a bioactive agent. |
| 06/06/2000 | US6071428 Amorphous, undercooled, glassy phase containing a water-soluble or water-swellable substance in an amorphous form; a sugar, which is capable of existing as a crystalline hydrate, is used as an agent to dehydrate the amorphous phase |
| 06/06/2000 | CA2206233C Combination dosage form comprising cetirizine and pseudoephedrine |
| 06/06/2000 | CA2101466C Taste-masking composition of bitter pharmaceutical agents |
| 06/06/2000 | CA2058975C Antiinflammatory gel preparation |
| 06/06/2000 | CA1341018C Immunotoxins based on inactivated diphtheria toxins for cancer chemotherapy |
| 06/06/2000 | CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 06/02/2000 | WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 06/02/2000 | WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 06/02/2000 | WO2000031098A1 Injectable anthelmintic formulation |
| 06/02/2000 | WO2000031084A1 Prostaglandin conjugates for treating or preventing bone disease |
| 06/02/2000 | WO2000030685A1 Pharmaceutical composition comprising bupropion hydrochloride |
| 06/02/2000 | WO2000030660A2 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 06/02/2000 | WO2000030658A1 Chitosan-based nitric oxide donor compositions |
| 06/02/2000 | WO2000030657A1 A process for producing an iron-dextran compound |
| 06/02/2000 | WO2000030654A1 Anti-asthmatic combinations comprising surface active phospholipids |
| 06/02/2000 | WO2000030647A1 Compositions comprising cefuroxime axetil |
| 06/02/2000 | WO2000030641A1 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 06/02/2000 | WO2000030622A2 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 06/02/2000 | WO2000030621A1 Pressure-sensitive adhesive gel composition for iontophoresis and apparatus therefor |
| 06/02/2000 | WO2000030619A1 Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith |
| 06/02/2000 | WO2000030618A1 Particles based on polyamino-acid(s) and methods for preparing same |
| 06/02/2000 | WO2000030617A1 Taste masking rapid release coating system |
| 06/02/2000 | WO2000030616A1 Dispersible phospholipid stabilized microparticles |
| 06/02/2000 | WO2000030615A1 Method of preparing stable suspensions of insoluble microparticles |
| 06/02/2000 | WO2000030614A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 06/02/2000 | WO2000030613A1 New process |
| 06/02/2000 | WO2000030609A1 Aqueous ophthalmic formulations comprising chitosan |
| 06/02/2000 | WO2000030608A1 Pressurised metered dose inhalers (mdi) |
| 06/02/2000 | WO2000030607A1 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a |
| 06/02/2000 | WO2000030605A2 Method for producing medicaments from plant extracts, in a solid form of administration |
| 06/02/2000 | WO2000030602A1 Oil bodies as topical delivery vehicles for active agents |
| 06/02/2000 | WO2000030586A1 Method of producing solid dosage forms |
| 06/02/2000 | WO2000030578A1 Enzymatic treatment and prevention of hypertrophic skin |
| 06/02/2000 | WO2000030454A1 Compositions and methods using cell fusion |
| 06/02/2000 | WO2000030449A1 Antiparasitic formulations |
| 06/02/2000 | WO2000013710A3 Hydrogel compositions for the controlled release administration of growth factors |
| 06/02/2000 | WO2000010525A3 Fish gelatinous composition for use as an ingredient in tablets |
| 06/02/2000 | WO2000010506A3 Angiogenesis inhibitors and uses thereof |
| 06/02/2000 | WO2000009179A3 Methods, instruments and materials for chondrocyte cell transplantation |
| 06/02/2000 | WO2000009084A3 Biodegradable microparticles gel composition |
| 06/02/2000 | WO1999061097A9 Alpha emitting constructs and uses thereof |
| 06/02/2000 | CA2698376A1 Pressurised metered dose inhalers (mdi) |
| 06/02/2000 | CA2353071A1 Oil bodies as topical delivery vehicles for active agents |
| 06/02/2000 | CA2352462A1 Adhesive gel composition for iontophoresis and devices therefor |
| 06/02/2000 | CA2351679A1 Prostaglandin conjugates for treating or preventing bone disease |
| 06/02/2000 | CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | CA2349290A1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 06/02/2000 | CA2348876A1 Compositions comprising cefuroxime axetil |
| 06/02/2000 | CA2332882A1 A process for producing an iron-dextran compound |
| 05/31/2000 | EP1004593A2 Backbone modified oligonucleotide analogues |
| 05/31/2000 | EP1004318A2 Cyclodextrin composition |
| 05/31/2000 | EP1004311A1 Evacuant comprising magnesium oxide |
| 05/31/2000 | EP1004296A1 Powder containing fat-soluble drug |
| 05/31/2000 | EP1004294A1 Pharmaceutical composition comprising a nitric oxide (NO) donating organic compound |
| 05/31/2000 | EP1003897A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 05/31/2000 | EP1003895A2 Cloning vectors for producing adenoviral minimal viruses |
| 05/31/2000 | EP1003772A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 05/31/2000 | EP1003771A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 05/31/2000 | EP1003711A1 Novel lipopolyamines, and the preparation and use thereof |
| 05/31/2000 | EP1003569A2 Sterile bioerodible implant device with improved biocompatability and method |
| 05/31/2000 | EP1003568A1 Hemostatic tissue sealants |
| 05/31/2000 | EP1003567A1 TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS |
| 05/31/2000 | EP1003559A2 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 05/31/2000 | EP1003558A1 Lipid-polyamide conjugates and compositions for nucleic acid delivery |
| 05/31/2000 | EP1003557A2 New salts with beneficial organoleptic properties |
| 05/31/2000 | EP1003556A2 Cationic reagents for transfection |
| 05/31/2000 | EP1003555A1 Controlled release of ophthalmic compositions |
| 05/31/2000 | EP1003551A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 05/31/2000 | EP1003550A1 Receptor specific transepithelial transport of therapeutics |
| 05/31/2000 | EP1003549A1 IMMUNOGENIC CONJUGATES COMPRISING A GROUP B MENINGOCOCCAL PORIN AND AN $i(H. INFLUENZAE) POLYSACCHARIDE |
| 05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/31/2000 | EP1003537A1 Et |
| 05/31/2000 | EP1003530A1 Eye treatments using synthetic thyroid hormone compositions |
| 05/31/2000 | EP1003528A1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 05/31/2000 | EP1003527A1 Polynucleotide compositions |